New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 17, 2012
19:17 EDTGALE, DFS, DMND, BAC, GPOR, XRTX, COn The Fly: After Hours Movers
HIGHER: Citigroup (C), up 0.50%, Bank of America (BAC), up 2%, and Discover Financial (DFS), up 2.2% all gained after being upgraded by Meredith Whitney speaking on CNBC... Xyratex (XRTX), up 6.8% after declaring a $2.00 special dividend... DOWN AFTER EARNINGS: Diamond Foods (DMND), down 3%... ALSO LOWER: Galena Biopharma (GALE), down 16% after announcing intent to offer common stock and warrants... Gulfport Energy (GPOR), down 3.6% after providing operational updates and 2013 production guidance.
News For C;BAC;DFS;XRTX;DMND;GALE;GPOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 25, 2015
12:22 EDTBACBank of America upgraded to Buy from Neutral at UBS
12:20 EDTBAC, COn The Fly: Top stock stories at midday
Subscribe for More Information
11:12 EDTC, BACNumerous analysts upgrade Bank of America amid market rebound
Subscribe for More Information
11:01 EDTBACStocks with call strike movement; MSFT BAC
Microsoft (MSFT) January 48 call option implied volatility decreased 9% to 28, Bank of America (BAC) December 18 call option implied volatility decreased 9% to 29 according to IVolatility.
09:59 EDTBACOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:13 EDTBACOn The Fly: Pre-market Movers
Subscribe for More Information
07:03 EDTBACBank of America upgraded on valuation at Bernstein
As noted earlier, Bernstein upgraded Bank of America to Outperform from Market Perform. The firm upgraded the stock on valuation. The firm also thinks the company has several potential longer term catalysts, i.e. higher interest rates, improved operating leverage, and expanding capital return. The firm believes that the bank's strong capital levels and ability to cut costs can protect it from macro risks.
06:43 EDTBACBank of America upgraded to Neutral from Underperform at Macquarie
Subscribe for More Information
06:11 EDTBACBank of America upgraded to Outperform on valuation at Baird
Subscribe for More Information
06:04 EDTBACBank of America upgraded to Outperform from Market Perform at Bernstein
Subscribe for More Information
August 24, 2015
16:00 EDTBACOptions Update; August 24, 2015
Subscribe for More Information
09:45 EDTBACOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Bank of America (BAC) upgraded to Outperform from Market Perform at Keefe Bruyette... Bristol-Myers (BMY) upgraded to Neutral from Underweight at Piper Jaffray... Chevron (CVX) upgraded to Neutral from Underperform at BofA/Merrill... Abercrombie & Fitch (ANF) upgraded to Overweight from Neutral... Nike (NKE) upgraded to Outperform from Market Perform at Telsey Advisory... DreamWorks (DWA) upgraded to Buy from Neutral at B. Riley... Caesarstone (CSTE) upgraded to Overweight from Equal Weight at Barclays... TransAlta (TAC) upgraded to Outperform from Market Perform at BMO Capital... Sarepta (SRPT) upgraded to Overweight from Neutral at Piper Jaffray... AutoZone (AZO) upgraded to Buy from Neutral at BofA/Merrill... Royal Dutch Shell (RDS.A) upgraded to Buy from Hold at Jefferies... Allscripts (MDRX) upgraded to Buy from Hold at Argus... China Unicom (CHU) upgraded to Buy from Hold at Jefferies... Ross Stores (ROST) upgraded to Buy from Neutral at Buckingham.
09:36 EDTBACActive equity options trading on open
Active equity options trading on open: AAPL FB BAC NFLX
07:19 EDTBACBank of America volatility at high end of range
Subscribe for More Information
07:07 EDTGALEIDMC recommends reduction of cardiac toxicity monitoring in Galena NeuVax trial
Galena Biopharma announced that the Independent Data Monitoring Committee, or IDMC, has recommended to the company that it can reduce the cardiac toxicity monitoring for patients in its NeuVax Phase 3 Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment, or PRESENT, clinical trial. The trial is being run under a Special Protocol Assessment, or SPA, approved by the FDA. Following its most recent IDMC meeting in June, the IDMC recommended routine cardiac monitoring could be reduced in the PRESENT trial and that such a reduction is justified and consistent with the pre-specified Cardiac Toxicity Monitoring Stopping Rules defined in the study protocol. The IDMC concluded that cardiac toxicity monitoring by echocardiogram, or ECHO, or multiple-gated acquisition, or MUGA, scans could be reduced. The IDMC had no other suggestions and recommended the trial continue as planned.
07:05 EDTCCitigroup volatility at high end of range
Citigroup August weekly call option implied volatility is at 39, October is at 30; compared to its 52-week range of 14 to 30, suggesting large near term price movement.
06:58 EDTBACBank of America upgraded to Outperform from Market Perform at Keefe Bruyette
Subscribe for More Information
August 21, 2015
16:01 EDTBAC, COptions Update; August 21, 2015
Subscribe for More Information
09:34 EDTBACActive equity options trading on open
Active equity options trading on open: AAPL FB BAC NFLX DIS TSLA TWTR
08:40 EDTBACCanadian Security Traders Association to hold a conference
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use